Breaking News Instant updates and real-time market news.

AVGO

Broadcom

$239.43

-0.89 (-0.37%)

, QCOM

Qualcomm

$55.20

0.19 (0.35%)

18:59
04/12/18
04/12
18:59
04/12/18
18:59

On The Fly: After Hours Movers

HIGHER: Broadcom (AVGO) up 4.5% on stock buyback... QualComm (QCOM) up 3.2% on CNBC report of take-private interest by former chairman Jacobs... Pulse Biosciences (PLSE) up 29.2% on positive NPS study results. LOWER: Zillow Group (ZG) down 4.7% on Q1 update... Dropbox (DBX) down 2.3% on Nomura Reduce initiation... Vermillion (VRML) down 15.3% on equity offering... SeaWorld (SEAS) down 4.2% on SEC Wells Notice.

AVGO

Broadcom

$239.43

-0.89 (-0.37%)

QCOM

Qualcomm

$55.20

0.19 (0.35%)

PLSE

Pulse Biosciences

$18.18

0.59 (3.35%)

ZG

Zillow

$53.77

0.36 (0.67%)

DBX

Dropbox

$33.27

0.95 (2.94%)

VRML

Vermillion

$1.30

0.029 (2.28%)

SEAS

SeaWorld

$15.40

-0.12 (-0.77%)

  • 08

    May

  • 13

    Apr

AVGO Broadcom
$239.43

-0.89 (-0.37%)

04/04/18
UBSW
04/04/18
INITIATION
Target $350
UBSW
Buy
Broadcom initiated with a Buy at UBS
UBS started Broadcom with a Buy rating and $350 price target.
04/05/18
04/05/18
NO CHANGE

UBS starts Semiconductors coverage, says sell Micron, Texas Instruments
UBS analyst Timothy Arcuri started coverage on the U.S. Semiconductors and Semi Equipment sector, expressing the view that consolidation and a slowdown in Moore's Law should actually lead to pricing power and inflationary effects that are still in the early innings. However, he also believes semis are still cyclical and sees some signs of caution moving into later 2018 and 2019. Arcuri, who is cautious on the memory cycle in the near-term, started Micron (MU) with a Sell rating and $35 price target, citing those cyclical memory concerns. He also has one other Sell rating among his 14 recommendations, on Texas Instruments (TXN), citing its fading leverage, a more level playing field for capital return and his cyclical concerns. Among the 14 stocks he initiated, Arcuri has 4 Buy ratings - Intel (INTC), given his above consensus call for datacenter group growth and what he sees as a mispricing of long-term growth potential; Marvell (MRVL) and Broadcom (AVGO), which he views as transformation stories; and KLA-Tencor (KLAC), on its migration to industrial tech and exposure to AI-related compute growth.
03/26/18
LEHM
03/26/18
INITIATION
Target $335
LEHM
Overweight
Broadcom reinstated with an Overweight at Barclays
Barclays analyst Blayne Curtis reinstated Broadcom Limited with an Overweight rating and $335 price target. The analyst sees "compelling upside" from current share levels but admits there will be an "M&A overhang given the lack of alternative large targets at these valuations."
03/20/18
NOMU
03/20/18
NO CHANGE
Target $300
NOMU
Buy
Broadcom price target lowered to $300 from $330 at Nomura Instinet
Nomura Instinet analyst Romit Shah lowered his price target for Broadcom (AVGO) to $300 citing disappoint in the company being unsuccessful in its attempt to acquire Qualcomm (QCOM). Acquisitions have been a key driver of growth, Shah tells investors in a research note. The analyst, however, believes Broadcom shares offer a good risk/reward and he keeps a Buy rating on the name.
QCOM Qualcomm
$55.20

0.19 (0.35%)

04/12/18
SBSH
04/12/18
INITIATION
Target $58
SBSH
Neutral
Qualcomm resumed with a Neutral at Citi
Citi analyst Christopher Danely resumed coverage of Qualcomm (QCOM) with a Neutral rating and $58 price target. The analyst believes the proposed acquisition of NXP Semiconductors (NXPI) could eventually drive earnings accretion of roughly 44% or $1.52, but he does not have confidence in the $500M in synergies. Danely expects a host of integration difficulties given differences in manufacturing, customer base, and NXP's merger with Freescale.
04/12/18
SBSH
04/12/18
INITIATION
Target $127.5
SBSH
Neutral
NXP Semiconductors resumed with a Neutral at Citi
Citi analyst Christopher Danely resumed coverage of NXP Semiconductors (NXPI) with a Neutral rating and $127.50 price target. The analyst expects Qualcomm (QCOM) to close the acquisition of NXP at the current proposed price of $127.50 per share. He believes, however, that there is "some potential for the deal to break due to approval from China given the trade war." If the deal falls apart, Danely expects NXP shares to trade to $90.
04/05/18
04/05/18
INITIATION

On The Fly: Top five analyst initiations
Catch up on today's top five analyst initiations with this list compiled by The Fly: 1. Spotify (SPOT) initiated with a Buy at Canaccord and Stifel. 2. Trade Desk (TTD) initiated with an Overweight at Piper Jaffray. 3. Saul Centers (BFS) initiated with a Neutral at B. Riley FBR. 4. Capital One (COF) and American Express (AXP) were initiated with a Buy at Citi while Discover (DFS) and Synchrony (SYF) were initiated with a Neutral. 5. Intel (INTC) initiated with a Buy at UBS while Qualcomm (QCOM) was initiated with a Neutral. This list is just a portion of The Fly's analyst coverage. To see The Fly's full Street Research coverage, click here.
04/05/18
UBSW
04/05/18
INITIATION
Target $56
UBSW
Neutral
Qualcomm initiated with a Neutral at UBS
UBS analyst Timothy Arcuri started Qualcomm with a Neutral rating and $56 price target, calling it a "show-me story."
PLSE Pulse Biosciences
$18.18

0.59 (3.35%)

ZG Zillow
$53.77

0.36 (0.67%)

04/04/18
DADA
04/04/18
INITIATION
Target $60
DADA
Neutral
Zillow initiated with a Neutral at DA Davidson
DA Davidson analyst Tom White initiated Zillow with a Neutral rating and a price target of $60. White notes that while Zillow has many 2018 tailwinds, such as strong audience engagement, robust product development pipeline, and the emerging Rentals/Mortgages/New Construction marketplaces, these positives are priced into the stock, which has rallied about 65% over the past 12 months. The analyst adds that he is not prepared to assume the total addressable market growth for Zillow required to assign the stock a Buy rating.
03/13/18
MSCO
03/13/18
NO CHANGE
Target $55
MSCO
Overweight
Zillow price target raised to $55 on rental opportunity at Morgan Stanley
Morgan Stanley analyst Jonathan Lanterman said he sees the rental opportunity as a $2.5B addressable market and he believes Zillow has an opportunity to move further down the spectrum to better monetize its opportunity in that space. By 2025, he thinks Zillow can grow Rentals to over $650M in revenues, which he notes would be nearly as big as Premier Agent is today. Lanterman raised his price target on Zillow to $55 from $50 and keeps an Overweight rating on the shares.
02/06/18
02/06/18
INITIATION

On The Fly: Top five analyst initiations
Catch up on today's top five analyst initiations with this list compiled by The Fly: 1. Redfin (RDFN) initiated with a Buy at Jefferies. The firm also initiated Zillow (Z, ZG) with a Hold. 2. Liberty Oilfield Services (LBRT) initiated with an Overweight at Piper Jaffray, an Overweight at Morgan Stanley, a Buy at Citi and Goldman Sachs, an Overweight at JPMorgan, an Outperform at Wells Fargo and an Outperform at Evercore ISI. 3. Industrial Logistics Property Trust (ILPT) initiated with a Buy at BofA/Merrill, an Outperform at RBC Capital and JMP Securities and a Neutral at UBS. 4. Angi Homeservices (ANGI) initiated with an Outperform at BMO Capital. 5. Jones Lang LaSalle (JLL), Newmark (NMRK) and CBRE Group (CBG) initiated with an Outperform at Raymond James. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
02/09/18
ADAM
02/09/18
NO CHANGE
Target $54
ADAM
Buy
Zillow still in early stages of growth, says Canaccord
Canaccord analyst Michael Graham said Zillow is still in the early stages of growing into a much larger company as it grows it portfolio of brands, renews focus on following consumers down the funnel, and aligns revenue more closely with its partners. Graham reiterated his Buy rating and raised his price target to $54 from $53 on Zillow shares.
DBX Dropbox
$33.27

0.95 (2.94%)

03/21/18
03/21/18
INITIATION

On The Fly: Top five analyst initiations
Catch up on today's top five analyst initiations with this list compiled by The Fly: 1. Celgene (CELG) reinstated with an Overweight at JPMorgan. 2. ConvergeOne (CVON) initiated with a Buy at BTIG. 3. Dropbox (DBX) initiated with a Buy at DA Davidson. 4. Diffusion Pharmaceuticals (DFFN) initiated with a Buy at H.C. Wainwright. 5. Xcerra (XCRA) initiated with a Buy at B. Riley FBR. This list is just a portion of The Fly's analyst coverage. To see The Fly's full Street Research coverage, click here.
03/21/18
DADA
03/21/18
INITIATION
Target $22
DADA
Buy
Dropbox initiated with a Buy at DA Davidson
DA Davidson analyst Rishi Jaluria initiated Dropbox with a Buy rating and a price target of $22 following the company's IPO pricing. Jaluria says that Dropbox offers a "differentiated strategy, rapid growth, strong cash flow margins, and a reasonable valuation". The analyst is also positive on the company's low marketing expenses thanks to its 90% of overall revenues coming from self-serve channels as well as becoming the second fastest technology company to reach $1B in revenues in just 11 years.
04/12/18
NOMU
04/12/18
INITIATION
Target $21
NOMU
Reduce
Dropbox initiated with a Reduce at Nomura Instinet
Nomura initiated Dropbox with a Reduce and $21 price target.
VRML Vermillion
$1.30

0.029 (2.28%)

08/30/17
ADAM
08/30/17
NO CHANGE
Target $2
ADAM
Buy
Vermillion could see material increase in 2018 reimbursement, says Canaccord
Canaccord analyst Mark Massaro noted Vermillion reported a shortfall in volumes in Q2 and guided to lower Q3 volumes due to a loss of a larger legacy customer. The analyst said the company is feeling good about being a winner from PAMA and, if implemented as planned, could see a material bump higher in reimbursement in 2018. Massaro maintained his Buy rating and lowered his price target to $1.75 from $2.50 on Vermillion shares.
09/25/17
ADAM
09/25/17
NO CHANGE
ADAM
Genomic Health, Vermillion among 'few winners' after PAMA news, says Canaccord
After the CMS released the proposed 2018 draft Medicare reimbursement rates for clinical lab tests under the Protecting Access to Medicare Act, or PAMA, which marks a major overhaul of Medicare reimbursement for tests, Canaccord analyst Mark Massaro said the cuts were greater than he expected. He identifies the "losers" after the news as LabCorp (LH), Quest Diagnostics (DGX) and GenMark (GNMK) while he sees Genomic Health (GHDX), VeraCyte (VCYT) and Vermillion (VRML) as among the "few winners."
SEAS SeaWorld
$15.40

-0.12 (-0.77%)

03/02/18
MACQ
03/02/18
DOWNGRADE
MACQ
Underperform
SeaWorld downgraded to Underperform from Neutral at Macquarie
03/02/18
03/02/18
DOWNGRADE

Underperform
SeaWorld downgraded to Underperform at Macquarie
As previously reported, Macquarie downgraded SeaWorld to Underperform from neutral and lowered its price target to $10 from $12. Analyst Matthew Brooks views the CEO departure as a negative, especially following the CFO departure in August. He thinks SeaWorld is over-leveraged and structurally challenged with too much debt and spending commitments. Brooks said valuation is too high for a stock with 5x leverage and falling EBITDA in the last two years. Any potential acquirers are likely to get a better deal if they wait and let falling fee-cash-flow and Fed tightening pressures reduce the acquisition cost, the analyst wrote in a note to investors.
02/27/18
STFL
02/27/18
NO CHANGE
Target $20
STFL
Buy
SeaWorld uncertainty creates opportunity, says Stifel
Stifel analyst Steven Wieczynski raised his price target for SeaWorld to $20 from $17, while reiterating a Buy rating on the shares. The analyst notes that news of CEO Joel Manby's unexpected departure is overshadowing the company's better than expected Q4 operating results and encouraging 2018-to-date business commentary. Given signs of building momentum in its underlying business fundamentals, the analyst's diminishing concerns regarding a potential Q1 debt covenant breach, and a "very compelling" valuation, Wieczynski encourages investors to aggressively accumulate SeaWorld shares at current levels.
03/09/18
SBSH
03/09/18
NO CHANGE
Target $15
SBSH
Neutral
SeaWorld consensus estimates have swung too far negative, says Citi
Citi analyst Jason Bazinet said he previously thought in mid-2017 that the consensus Street view on SeaWorld's 2018 EBITDA was likely too bullish. However, since then, SeaWorld missed and lowered guidance twice and now the consensus 2018 EBITDA estimate has been cut by $85M, which he sees as too far a swing given he has lowered his own estimate by only $30M to $325M, versus the $311M consensus. The analyst, who thinks the consensus gives no credit for recent attendance rebounds in California and Florida, is too conservative on 2018 cost cuts, and factors in no international attendance stabilization, keeps a Neutral rating on the stock but raised his price target on the shares to $15 from $13.

TODAY'S FREE FLY STORIES

KSS

Kohl's

$65.28

0.83 (1.29%)

10:40
11/21/18
11/21
10:40
11/21/18
10:40
Options
Bullish call spread in Kohls after recent weakness in shares »

Bullish call spread in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

10:40
11/21/18
11/21
10:40
11/21/18
10:40
General news
The U.S. 1.4% October existing home sales rise »

The U.S. 1.4% October…

10:40
11/21/18
11/21
10:40
11/21/18
10:40
General news
Energy Action: NYMEX crude »

Energy Action: NYMEX…

DE

Deere

$145.63

7.14 (5.16%)

10:37
11/21/18
11/21
10:37
11/21/18
10:37
Hot Stocks
Breaking Hot Stocks news story on Deere »

Deere raises 2022…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Nov

  • 27

    Nov

DE

Deere

$144.30

5.81 (4.20%)

10:32
11/21/18
11/21
10:32
11/21/18
10:32
Hot Stocks
Breaking Hot Stocks news story on Deere »

Deere sees grain demand…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Nov

  • 27

    Nov

10:31
11/21/18
11/21
10:31
11/21/18
10:31
General news
Crude inventories for week of November 16 »

Crude oil inventories…

JNJ

Johnson & Johnson

$143.12

-3.32 (-2.27%)

10:30
11/21/18
11/21
10:30
11/21/18
10:30
Options
J&J puts active as shares see relative weakness »

J&J puts active as…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Dec

10:30
11/21/18
11/21
10:30
11/21/18
10:30
General news
FX Action: The dollar »

FX Action: The dollar…

DE

Deere

$143.26

4.77 (3.44%)

10:29
11/21/18
11/21
10:29
11/21/18
10:29
Hot Stocks
Deere says U.S. farmers, dealers 'cautiously optimistic' »

Says record yields,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Nov

  • 27

    Nov

AVGO

Broadcom

$229.32

1.63 (0.72%)

, VLKAY

Volkswagen

$0.00

(0.00%)

10:28
11/21/18
11/21
10:28
11/21/18
10:28
Periodicals
Breaking Periodicals news story on Broadcom, Volkswagen »

Broadcom said to settle…

AVGO

Broadcom

$229.32

1.63 (0.72%)

VLKAY

Volkswagen

$0.00

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Dec

AMZN

Amazon.com

$1,520.59

24.99 (1.67%)

10:27
11/21/18
11/21
10:27
11/21/18
10:27
Periodicals
Amazon contacting some users about error that exposed emails, The Verge says »

Amazon has been emailing…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Nov

  • 04

    Dec

10:25
11/21/18
11/21
10:25
11/21/18
10:25
General news
U.S. leading index rose 0.1% to 112.1 in October, another record high »

U.S. leading index rose…

TLC

Taiwan Liposome

$0.00

(0.00%)

10:21
11/21/18
11/21
10:21
11/21/18
10:21
Syndicate
Taiwan Liposome opens at $6.06, IPO priced at $5.80 per share »

Taiwan Liposome (TLC)…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Nov

NVDA

Nvidia

$150.33

1.19 (0.80%)

10:20
11/21/18
11/21
10:20
11/21/18
10:20
Technical Analysis
Technical Take: Nvidia goes negative on the day »

At time of writing the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Nov

  • 10

    Dec

10:20
11/21/18
11/21
10:20
11/21/18
10:20
General news
U.S. October existing home sales bounced 1.4% to 5.220 M »

U.S. October existing…

JD

JD.com

$20.24

0.75 (3.85%)

10:20
11/21/18
11/21
10:20
11/21/18
10:20
Options
Third day of call buying in JD »

Third day of call buying…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

10:20
11/21/18
11/21
10:20
11/21/18
10:20
General news
Treasury Action: yields steadied above lows »

Treasury Action: yields…

10:20
11/21/18
11/21
10:20
11/21/18
10:20
General news
The Michigan sentiment drop »

The Michigan sentiment…

$NSD

NASDAQ Market Internals

$0.00

(0.00%)

10:17
11/21/18
11/21
10:17
11/21/18
10:17
Technical Analysis
NASDAQ market internals summary »

Volume is average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$NYE

NYSE Market Internals

$0.00

(0.00%)

10:16
11/21/18
11/21
10:16
11/21/18
10:16
Technical Analysis
NYSE market internals summary »

Volume is average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

10:15
11/21/18
11/21
10:15
11/21/18
10:15
General news
Breaking General news story  »

Week of 11/16 EIA…

WDC

Western Digital

$46.68

0.99 (2.17%)

10:10
11/21/18
11/21
10:10
11/21/18
10:10
Options
Western Digital weekly calls active as shares gain 3% »

Western Digital weekly…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 04

    Dec

10:10
11/21/18
11/21
10:10
11/21/18
10:10
General news
U.S. consumer sentiment fell 1.1 points to 97.5 in the final November print »

U.S. consumer sentiment…

BGNE

BeiGene

$126.50

0.63 (0.50%)

, GMDA

Gamida Cell

$9.50

(0.00%)

10:09
11/21/18
11/21
10:09
11/21/18
10:09
Initiation
On The Fly: Top five analyst initiations »

Catch up on today's…

BGNE

BeiGene

$126.50

0.63 (0.50%)

GMDA

Gamida Cell

$9.50

(0.00%)

MRKR

Marker Therapeutics

$6.37

0.11 (1.76%)

ARCE

Arco Platform

$22.65

(0.00%)

NVT

nVent Electric

$24.43

0.25 (1.03%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Nov

  • 27

    Nov

  • 28

    Nov

  • 01

    Dec

  • 03

    Dec

  • 07

    Dec

LOW

Lowe's

$86.80

0.65 (0.75%)

, GS

Goldman Sachs

$193.69

2.35 (1.23%)

10:09
11/21/18
11/21
10:09
11/21/18
10:09
Downgrade
On The Fly: Top five analyst downgrades »

Catch up on today's…

LOW

Lowe's

$86.80

0.65 (0.75%)

GS

Goldman Sachs

$193.69

2.35 (1.23%)

CS

Credit Suisse

$11.93

0.21 (1.79%)

SWGAY

Swatch Group

$0.00

(0.00%)

LNT

Alliant Energy

$44.64

-0.62 (-1.37%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Nov

  • 27

    Nov

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.